Haviland Kate

Avg. Two Year Performance

No purchase track record
(11%) Avg. Sale Return
(5%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)2%(1%)(1%)(11%)
Sale Success Rate8 of 198 of 199 of 196 of 192 of 19
Drugs » Biotechnology

CHIEF EXECUTIVE OFFICER:

Holdings: 153.18K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

($1.13M) Net Amount
Buy:0--
Sell:($1.13M)$90.69
Other » Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--